Abstract
Herpes simplex virus encephalitis (HSVE) is a disease of public health concern, but its burden on the healthcare of United States has not been adequately assessed recently. We aimed to define the incidence, complications and outcomes of HSVE in the recent decade by analyzing data from a nationally representative database. Healthcare Cost and Utilization Project databases were utilized to identify patients with primary discharge diagnosis of HSVE. Annual hospitalization rate was estimated and several preselected inpatient complications were identified. Regression analyses were used to identify mortality predictors. Key epidemiological factors were compared with those from other countries. Total 4871 patients of HSVE were included in our study. The annual hospitalization rate was 10.3 ± 2.2 cases/million in neonates, 2.4 ± 0.3 cases/million in children and 6.4 ± 0.4 cases/million in adults. Median age was 57 years and male:female incidence ratio was 1:1. Rates of some central nervous system complications were seizures (38.4%), status epilepticus (5.5%), acute respiratory failure (20.1%), ischemic stroke (5.6%) and intracranial hemorrhage (2.7%), all of which were significantly associated with mortality. In-hospital mortality in neonates, children and adults were 6.9, 1.2 and 7.7%, respectively. HSVE still remains a potentially lethal infectious disease with high morbidity and mortality. Most recent epidemiological data in this study may help understanding this public health disease, and the patient outcome data may have prognostic significance.
Similar content being viewed by others
References
Glaser C, Honarmand S, Anderson L et al (2006) Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 43:1565–1577
George BP, Schneider EB, Venkatesan A (2014) Encephalitis hospitalization rates and inpatient mortality in the United States, 2000–2010. PLoS One 9:e104169
Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA (2012) The frequency of autoimmune N-methyl-d-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012:cir1038
Lai M, Hughes EG, Peng X et al (2009) AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65:424–434
Lancaster E, Lai M, Peng X et al (2010) Antibodies to the GABA B receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9:67–76
Dalmau J, Gleichman AJ, Hughes EG et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098
Lai M, Huijbers MG, Lancaster E et al (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9:776–785
Mailles A, Stahl J-P (2009) Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 49:1838–1847
Singh TD, Fugate JE, Rabinstein AA (2015) The spectrum of acute encephalitis. Causes, management, and predictors of outcome. Neurology 84:359–366
Whitley RJ, Soong S-J, Dolin R, Galasso GJ, Ch’ien LT, Alford CA (1977) Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis: National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study. N Engl J Med 297:289–294
Erdem H, Cag Y, Ozturk-Engin D et al (2015) Results of a multinational study suggest the need for rapid diagnosis and early antiviral treatment at the onset of herpetic meningoencephalitis. Antimicrob Agents Chemother 59:3084–3089
Sköldenberg B, Alestig K, Burman L et al (1984) Acyclovir versus vidarabine in herpes simplex encephalitis: randomised multicentre study in consecutive Swedish patients. Lancet 324:707–711
Dodson MG, Kerman RH, Lange CF, Stefani SS, O’Leary JA (1977) T and B cells in pregnancy. Obstet Gynecol 49:299–300
Riancho J, Delgado-Alvarado M, Sedano MJ, Polo JM, Berciano J (2013) Herpes simplex encephalitis: clinical presentation, neurological sequelae and new prognostic factors. Ten years of experience. Neurol Sci 34:1879–1881
Jouan Y, Grammatico-Guillon L, Espitalier F, Cazals X, François P, Guillon A (2015) Long-term outcome of severe herpes simplex encephalitis: a population-based observational study. Crit Care 19:1–9
Jain P, Jain A, Kumar A et al (2014) Epidemiology and etiology of acute encephalitis syndrome in North India. Jpn J Infect Dis 67:197–203
Sheybani F, Arabikhan H, Naderi H (2013) Herpes simplex encephalitis (HSE) and its outcome in the patients who were admitted to a tertiary care hospital in Mashhad, Iran, over a 10-year period. J Clin Diagn Res 7:1626
Dagsdóttir HM, Sigurðardóttir B, Gottfreðsson M et al (2014) Herpes simplex encephalitis in Iceland 1987–2011. SpringerPlus 1:1–7
Sili U, Kaya A, Mert A, Group HES (2014) Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients. J Clin Virol 60:112–118
HCUP Overview (2016) Healthcare Cost and Utilization Project (HCUP). https://www.hcup-us.ahrq.gov/overview.jsp. Accessed 25 May 2016
Hjalmarsson A, Blomqvist P, Sköldenberg B (2007) Herpes simplex encephalitis in Sweden, 1990–2001: incidence, morbidity, and mortality. Clin Infect Dis 45:875–880
Barbadoro P, Marigliano A, Ricciardi A, D’Errico M, Prospero E (2012) Trend of hospital utilization for encephalitis. Epidemiol Infect 140:753–764
Population, total; The World Bank. http://data.worldbank.org/indicator/SP.POP.TOTL. Accessed 25 May 2016
International Data Base; United States Census Bureau. https://www.census.gov/population/international/data/idb/informationGateway.php. Accessed 25 May 2016
Adams H, Miller D (1973) Herpes simplex encephalitis: a clinical and pathological analysis of twenty-two cases. Postgrad Med J 49:393
Kennedy P, Adams J, Graham D, Clement G (1988) A clinico-pathological study of herpes simplex encephalitis. Neuropathol Appl Neurobiol 14:395–415
Raschilas F, Wolff M, Delatour F et al (2002) Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis 35:254–260
McGrath N, Anderson N, Croxson M, Powell K (1997) Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry 63:321–326
Granerod J, Ambrose HE, Davies NW et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10:835–844
Rodríguez-Sainz A, Escalza-Cortina I, Guio-Carrión L et al (2013) Intracerebral hematoma complicating herpes simplex encephalitis. Clin Neurol Neurosurg 115:2041–2045
Zis P et al (2016) Herpes simplex virus type 2 encephalitis as a cause of ischemic stroke: case report and systematic review of the literature. J Stroke Cerebrovasc Dis 25(2):335–339
Sas AM et al (2009) Herpes simplex virus type-1 encephalitis and occipital ischemic stroke. Pediatr Neurol 41(4):294–296
Burón Mediavilla F, Rodríguez Borregan J, Miñambres E et al (2005) Encefalitis herpética en adultos: 23 casos. Anales de medicina interna 2005:473–477 (SciELO Espana)
Puchhammer-Stöckl E, Popow-Kraupp T, Heinz FX, Mandl CW, Kunz C (1990) Establishment of PCR for the early diagnosis of herpes simplex encephalitis. J Med Virol 32:77–82
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors of this manuscript report no conflict of interest.
Ethical standards
This study used de-identified patient databases. Therefore, this study did not require IRB review in accordance with the Code of Federal Regulations, 45 CFR 46.
Funding
The authors do not report any external source of funding.
Rights and permissions
About this article
Cite this article
Modi, S., Mahajan, A., Dharaiya, D. et al. Burden of herpes simplex virus encephalitis in the United States. J Neurol 264, 1204–1208 (2017). https://doi.org/10.1007/s00415-017-8516-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-017-8516-x